Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2012 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: Biotech Jim who wrote (433)	1/2/2013 7:18:53 PM
From: scaram(o)uche	Respond to of 513

"If you're a blood-thirsty, high-risk biotech investor....." seekingalpha.com Don't understand the jargon in that report, but the meaning of 6X is clear. Thanks. Yahoo has the price:book at <3, so George probably owns it too. :-) So we should consider it to be a development-only company, and forget any deep pipe? Or, since you mentioned combinatoRx, are there 231 live, deep-pipe molecules? Ha! Looks like this will be the first phase II for data, matures August...... clinicaltrials.gov I'll take a look, can see why your eye is on it. Thanks.